AU3376297A - Human thyrotropin receptor compositions and use thereof - Google Patents

Human thyrotropin receptor compositions and use thereof

Info

Publication number
AU3376297A
AU3376297A AU33762/97A AU3376297A AU3376297A AU 3376297 A AU3376297 A AU 3376297A AU 33762/97 A AU33762/97 A AU 33762/97A AU 3376297 A AU3376297 A AU 3376297A AU 3376297 A AU3376297 A AU 3376297A
Authority
AU
Australia
Prior art keywords
thyrotropin receptor
receptor compositions
human thyrotropin
compositions
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33762/97A
Other languages
English (en)
Inventor
Sandra Mclachlan
Basil Rapoport
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3376297A publication Critical patent/AU3376297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU33762/97A 1996-06-05 1997-06-05 Human thyrotropin receptor compositions and use thereof Abandoned AU3376297A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1917196P 1996-06-05 1996-06-05
US60019171 1996-06-05
PCT/US1997/009624 WO1997046206A2 (fr) 1996-06-05 1997-06-05 Compositions a base de recepteur de la thyrotropine humaine

Publications (1)

Publication Number Publication Date
AU3376297A true AU3376297A (en) 1998-01-05

Family

ID=21791804

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33762/97A Abandoned AU3376297A (en) 1996-06-05 1997-06-05 Human thyrotropin receptor compositions and use thereof

Country Status (6)

Country Link
EP (1) EP0959896B1 (fr)
JP (1) JP2000512280A (fr)
AT (1) ATE510552T1 (fr)
AU (1) AU3376297A (fr)
CA (1) CA2258720A1 (fr)
WO (1) WO1997046206A2 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
JP4713798B2 (ja) 1999-06-29 2011-06-29 マンカインド コーポレイション ペプチドおよびタンパク質の薬学的因子の精製および安定化
WO2002034042A2 (fr) * 2000-10-26 2002-05-02 Deltagen, Inc. Souris transgeniques contenant des disruptions geniques du recepteur de l'hormone de stimulation thyroidienne (tch-r)
ES2300568T3 (es) 2002-03-20 2008-06-16 Mannkind Corporation Aparato de inhalacion.
MX2007001903A (es) 2004-08-20 2007-08-02 Mannkind Corp Catalisis de sintesis de dicetopiperazina.
DK1791542T3 (en) 2004-08-23 2015-06-15 Mannkind Corp Diketopiperazinsalte for pharmaceutical delivery
CA2621806C (fr) 2005-09-14 2016-08-02 Mannkind Corporation Procede de preparation de medicaments fonde sur l'accroissement de l'affinite des surfaces de microparticules cristallines pour des principes actifs
CN101389348A (zh) 2006-02-22 2009-03-18 曼金德公司 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
EP3281663B8 (fr) 2008-06-13 2022-09-21 MannKind Corporation Inhalateur de poudre sèche alimenté par la respiration pour l'administration de médicaments
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
ES2421385T3 (es) 2008-06-20 2013-09-02 Mannkind Corp Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
WO2010105094A1 (fr) 2009-03-11 2010-09-16 Mannkind Corporation Appareil, système et procédé de mesure de résistance d'un inhalateur
ES2943333T3 (es) 2009-06-12 2023-06-12 Mannkind Corp Micropartículas de dicetopiperazina con superficies específicas definidas
EP2496295A1 (fr) 2009-11-03 2012-09-12 MannKind Corporation Appareil et méthode de simulation d'efforts d'inhalation
CA2801936C (fr) 2010-06-21 2021-06-01 Mannkind Corporation Systeme et procede d'administration de medicament sous la forme d'une poudre seche
CN105667994B (zh) 2011-04-01 2018-04-06 曼金德公司 用于药物药盒的泡罩包装
WO2012174472A1 (fr) 2011-06-17 2012-12-20 Mannkind Corporation Microparticules de dicétopipérazine de capacité élevée
KR20140095483A (ko) 2011-10-24 2014-08-01 맨카인드 코포레이션 통증을 치료하기 위한 방법 및 조성물
CN104619369B (zh) 2012-07-12 2018-01-30 曼金德公司 干粉药物输送系统和方法
WO2014066856A1 (fr) 2012-10-26 2014-05-01 Mannkind Corporation Compositions et procédés de vaccin antigrippal inhalable
US10421729B2 (en) 2013-03-15 2019-09-24 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
ES2747634T3 (es) 2013-05-14 2020-03-11 Siemens Healthcare Diagnostics Inc Formulaciones líquidas estabilizadas que contienen receptores
CN114848614A (zh) 2013-07-18 2022-08-05 曼金德公司 热稳定性干粉药物组合物和方法
CA2920488C (fr) 2013-08-05 2022-04-26 Mannkind Corporation Appareil d'insufflation et procedes
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0557273A1 (fr) * 1990-11-15 1993-09-01 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Gene de rat recepteur de thyrotropine et utilisation dudit gene

Also Published As

Publication number Publication date
WO1997046206A2 (fr) 1997-12-11
EP0959896B1 (fr) 2011-05-25
EP0959896A2 (fr) 1999-12-01
JP2000512280A (ja) 2000-09-19
EP0959896A4 (fr) 2005-03-02
ATE510552T1 (de) 2011-06-15
CA2258720A1 (fr) 1997-12-11

Similar Documents

Publication Publication Date Title
AU3376297A (en) Human thyrotropin receptor compositions and use thereof
IL128003A0 (en) Therapeutic multispecific compounds comprised of anti-fcalpha receptor antibodies
MX9803992A (es) Metodos para incrementar la masa de tejido muscular usando composiciones de la proteina ob.
AU4230493A (en) Diphtheria toxin receptor-binding region
YU20600A (sh) Nova upotreba antagonista 5-ht3 receptora
MXPA05014152A (es) Anticuerpos dirigidos a los mutantes de delecion de receptor de factor de crecimiento epidermico y sus usos.
NZ324500A (en) Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
CA2310888A1 (fr) Anticorps monoclonaux naturels humains
AU5624699A (en) Use of 5ht-6 antagonists
AU3508497A (en) Androgen receptor modulator compounds and methods
AU4072397A (en) Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor
AU4622297A (en) Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
EP1382597A3 (fr) Composés modulateurs des récepteurs des stéroides et procédés d'utilisations
GB9317104D0 (en) Therapeutic heterocycles
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
AU2649597A (en) Non-invasive real time diagnosis of migraine
AU2990695A (en) Mucin-derived proteins for the diagnosis, imaging, and therapy of human cancer
AU5369996A (en) Monoclonal antibody against human receptor protein 4-1bb and methods of its use for treatment of diseases
HK1025500A1 (en) Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
AU5506896A (en) Human p2x4 receptor splice-variants
AU9363398A (en) Hepatitis c receptor protein cd81
AU3745795A (en) Use of CCK-B receptor antagonists for the treatment of sleepdisorders
IL131478A0 (en) Methods for treatment of scar tissue
EP1039931A4 (fr) Anticorps de recombinaison multivalents destines au traitement d'infections dues au rhinovirus humain (hrv)
AU3416995A (en) Endothelin receptor antagonists

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted